buthionine sulfoximine has been researched along with Adenoma, beta-Cell in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andersen, HU; Darville, MI; Eizirik, DL; Karlsen, AE; Mandrup-Poulsen, T; Nikulina, MA | 1 |
1 other study(ies) available for buthionine sulfoximine and Adenoma, beta-Cell
Article | Year |
---|---|
Glutathione depletion inhibits IL-1 beta-stimulated nitric oxide production by reducing inducible nitric oxide synthase gene expression.
Topics: Animals; Antineoplastic Agents, Alkylating; Buthionine Sulfoximine; Carmustine; Cell Separation; Cells, Cultured; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flow Cytometry; Gene Expression; Glutathione; Insulin; Insulinoma; Interleukin-1; Islets of Langerhans; Maleates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Oxidation-Reduction; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors | 2000 |